Expanded Program on Immunization
Expanded Program on Immunization (EPI) is a global initiative aimed at ensuring that all children have access to routinely recommended vaccines. Initiated by the World Health Organization (WHO) in 1974, the program focuses on vaccinating children against several key diseases that are preventable by vaccination, thereby reducing morbidity and mortality rates among children under the age of five.
Background
Before the introduction of EPI, diseases such as polio, measles, tetanus, whooping cough, diphtheria, and tuberculosis caused significant morbidity and mortality among children worldwide. Recognizing the need to combat these diseases, the WHO launched the EPI with the goal of making vaccines against these diseases accessible to all children regardless of their geographical location or socio-economic status.
Goals and Objectives
The primary goal of the EPI is to increase vaccine coverage among children to reduce the incidence of vaccine-preventable diseases. Specific objectives include:
- To ensure that all children and pregnant women have access to recommended vaccines.
- To achieve and maintain high immunization coverage (at least 90% nationally and 80% in every district or equivalent administrative unit).
- To introduce new and under-utilized vaccines into national immunization programs.
- To strengthen health systems to effectively deliver immunization services.
Key Vaccines
The EPI targets several key diseases for vaccination, including:
- Polio
- Measles
- Tetanus
- Whooping Cough (Pertussis)
- Diphtheria
- Tuberculosis
- Hepatitis B
- Haemophilus influenzae type b (Hib)
- Rotavirus
- Pneumococcal disease
Implementation
Implementation of the EPI varies by country but generally involves the integration of immunization services into the broader health care system. This includes planning and logistics for vaccine procurement and distribution, training health care workers, conducting public awareness campaigns, and monitoring and evaluation of vaccine coverage and disease surveillance.
Challenges
Despite significant progress, the EPI faces several challenges, including:
- Vaccine hesitancy among populations.
- Inadequate health infrastructure in some regions.
- Insufficient funding and resources.
- Conflicts and natural disasters disrupting vaccine delivery.
Impact
The EPI has had a profound impact on global child health, significantly reducing the incidence of vaccine-preventable diseases. For example, polio has been eradicated in most parts of the world, and measles and tetanus have seen dramatic declines in incidence.
Future Directions
The future of the EPI involves addressing the remaining challenges to achieve universal vaccine coverage. This includes integrating new vaccines into the program, improving health systems, and ensuring sustainable financing. The EPI also aims to leverage new technologies and innovations in vaccine development and delivery.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD